Formulir Kontak

Nama

Email *

Pesan *

Cari Blog Ini

Atricure To Double The Size Of Its Warren County Headquarters

AtriCure to Double the Size of Its Warren County Headquarters

Continued Growth for Warren County and AtriCure

Company to Create 400 New Full-Time Jobs

Mason, Ohio – August 17, 2023 – AtriCure, Inc. (NASDAQ: ATRC), a leading innovator in surgical ablation technologies for the treatment of atrial fibrillation (Afib) and left atrial appendage management, today announced plans to double the size of its Warren County headquarters. The expansion will create 400 new full-time jobs in the Mason area.

The expansion is a result of AtriCure's continued growth and success. The company has seen strong demand for its products, which are used to treat Afib, a common heart arrhythmia that can lead to stroke and other serious complications.

"We are excited to announce this expansion, which will allow us to continue to grow our business and create jobs in Warren County," said Michael Carrel, President & CEO of AtriCure. "This is a testament to the strength of our team and the demand for our products."

The expansion will add 100,000 square feet to AtriCure's existing facility in Mason. The new space will be used for manufacturing, research and development, and office space.

"This is great news for Warren County," said Commissioner Dave Young. "AtriCure is a major employer in our community, and this expansion will create even more jobs and help to boost our economy."

AtriCure expects to complete the expansion by the end of 2024.

About AtriCure

AtriCure, Inc. is a leading innovator in surgical ablation technologies for the treatment of atrial fibrillation (Afib) and left atrial appendage management. We are dedicated to developing, manufacturing, and selling products that improve the outcomes of cardiac surgery patients.

Our mission is to restore hope, improve lives, and elevate care for patients with atrial fibrillation and related conditions.

We are headquartered in Mason, Ohio, and have operations in the United States, Europe, Asia, and Australia.

Contact Information

Investor Relations

Michael Mogul

513-755-4515

ir@atricure.com


Komentar